Venous Thromboembolism Taskforce Audit Program

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00535171
Recruitment Status : Completed
First Posted : September 26, 2007
Last Update Posted : January 22, 2010
Information provided by:

Brief Summary:

To determine the effect of an interventional campaign run by a dedicated "VTE Nurse Educator" over a 6-month period and the effect on prophylaxis rates.

To determine the proportion of medically admitted patients with risk factors for VTE.

To assess and compare the use of venous thromboembolism (VTE) prophylaxis in hospitalized medical patients versus recommendations and current guidelines.

To determine the patient characteristics of those deemed to be at risk of VTE. To determine the proportion of patients receiving appropriate thromboprophylaxis for their risk.

To determine the type and duration (where possible) of prophylaxis used.

Condition or disease
Venous Thrombosis

Study Type : Observational
Actual Enrollment : 8764 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Venous Thromboembolism Taskforce Audit Program
Study Start Date : June 2007
Actual Primary Completion Date : August 2008

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Venous thromboembolism in medical patients bedridden due to acute illness.

Inclusion Criteria:

  • Hospital admission for an acute illness with an in-patient hospital stay of 3 days or more.

Exclusion Criteria:

  • Patients who have undergone any type of surgery during current admission
  • Patients who are admitted to a ward or department that is excluded from this study e.g psychiatric, paediatric, maternity, intensive care unit, coronary care unit.
  • Prior enrollment in this protocol during current admission
  • Prior enrollment in a VTE study involving pharmaceutical or mechanical treatment within last 90 days.
  • Admission for suspected or diagnosed deep vein thrombosis

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00535171

MacQuarie Park, Australia
Sponsors and Collaborators
Study Director: Fiona Howard Sanofi

Responsible Party: Medical Affairs Study Director, sanofi-aventis Identifier: NCT00535171     History of Changes
Other Study ID Numbers: DIREG_L_01927
First Posted: September 26, 2007    Key Record Dates
Last Update Posted: January 22, 2010
Last Verified: January 2010

Additional relevant MeSH terms:
Venous Thromboembolism
Venous Thrombosis
Embolism and Thrombosis
Vascular Diseases
Cardiovascular Diseases